Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis.

M Zaffaroni1, S Rossini, A Ghezzi

  • 1Centro Studi Sclerosis Multipla, Universita di Milano, Ospedale S. Antonio Abate, Gallarate, Italy.

Journal of Neurology
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

Genome-wide spectrum of coding DNA variations in Indian patients with amyotrophic lateral sclerosis.

Journal of neurology·2026
Same journal

Number needed to treat and harm for lecanemab and donanemab in early Alzheimer disease.

Journal of neurology·2026
Same journal

Genetic spectrum and clinical features of PMP22 point mutations in Japanese Charcot-Marie-Tooth disease.

Journal of neurology·2026
Same journal

Migraine and auditory dysfunction: beyond comorbidity.

Journal of neurology·2026
Same journal

Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.

Journal of neurology·2026
Same journal

Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.

Journal of neurology·2026
See all related articles

Multiple sclerosis patients, particularly those with chronic-progressive forms, show reduced CD4+CD45+ T-cells, potentially indicating altered immune cell maturation and disease progression.

Area of Science:

  • Immunology
  • Neuroimmunology
  • Cell Biology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Immune cell dysregulation, particularly T-lymphocytes, is implicated in MS pathogenesis.
  • Specific lymphocyte subpopulations may serve as biomarkers for disease activity and progression.

Purpose of the Study:

  • To investigate the levels of circulating lymphocyte subpopulations in patients with multiple sclerosis compared to healthy controls.
  • To determine if specific T-cell subsets, defined by CD45 expression, are altered in chronic-progressive MS.
  • To explore the relationship between CD4+CD45+ cells and other T-cell subsets (CD8+) in MS.

Main Methods:

  • Analysis of circulating lymphocyte subpopulations using anti-CD45 and T-cell-specific monoclonal antibodies.

Related Experiment Videos

  • Quantification of CD4+CD45+ cell percentages and absolute numbers.
  • Comparison of cell counts between 77 MS patients and 38 healthy controls.

    • Main Results:

    • A significant decrease in CD4+CD45+ cell percentages and absolute numbers was observed in chronic-progressive MS patients.
    • Reduced CD45+ cell subsets and CD45+ cells relative to CD4+ cells were found in chronic-progressive MS.
    • CD4+CD45+ cells did not correlate with CD8+ cell counts, suggesting functional rather than numerical effects.

    Conclusions:

    • The reduction of CD4+CD45+ cells (suppressor inducer T-cells/naive T-cells) in active MS may indicate increased conversion to memory cells.
    • This altered lymphocyte maturation pathway could be a key factor in MS pathogenesis.
    • Understanding these T-cell dynamics may offer new insights into multiple sclerosis mechanisms.